|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
DeSantis CE, Ma J, Gaudet MM, Newman LA,
Miller KD, Goding Sauer A, Jemal A and Siegel RL: Breast cancer
statistics, 2019. CA Cancer J Clin. 69:438–451. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin: Feb 4, 2021 (Epub ahead
of print). doi: 10.3322/caac.21660.
|
|
4
|
Schwartz RS and Erban JK: Timing of
metastasis in breast cancer. N Engl J Med. 376:2486–2488.
2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mouche A, Archambeau J, Ricordel C,
Chaillot L, Bigot N, Guillaudeux T, Grenon M and Pedeux R: ING3 is
required for ATM signaling and DNA repair in response to DNA double
strand breaks. Cell Death Differ. 26:2344–2357. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ludwig S, Klitzsch A and Baniahmad A: The
ING tumor suppressors in cellular senescence and chromatin. Cell
Biosci. 1(25)2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gou WF, Yang XF, Shen DF, Zhao S, Sun HZ,
Luo JS and Zheng HC: Immunohistochemical profile of ING3 protein in
normal and cancerous tissues. Oncol Lett. 13:1631–1636.
2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Shiseki M, Nagashima M, Pedeux RM,
Kitahama-Shiseki M, Miura K, Okamura S, Onogi H, Higashimoto Y,
Appella E, Yokota J and Harris CC: p29ING4 and p28ING5 bind to p53
and p300, and enhance p53 activity. Cancer Res. 63:2373–2378.
2003.PubMed/NCBI
|
|
9
|
Bose P, Thakur SS, Brockton NT, Klimowicz
AC, Kornaga E, Nakoneshny SC, Riabowol KT and Dort JC: Tumor cell
apoptosis mediated by cytoplasmic ING1 is associated with improved
survival in oral squamous cell carcinoma patients. Oncotarget.
5:3210–3219. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang R, Jin J, Shi J and Hou Y: INGs are
potential drug targets for cancer. J Cancer Res Clin Oncol.
143:189–197. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Dantas A, Al Shueili B, Yang Y, Nabbi A,
Fink D and Riabowol K: Biological functions of the ING proteins.
Cancers (Basel). 11(1817)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Liu XL, Meng J, Zhang XT, Liang XH, Zhang
F, Zhao GR and Zhang T: ING5 inhibits lung cancer invasion and
epithelial-mesenchymal transition by inhibiting the WNT/β-catenin
pathway. Thorac Cancer. 10:848–855. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Liu XL, Zhang XT, Meng J, Zhang HF, Zhao
Y, Li C, Sun Y, Mei QB, Zhang F and Zhang T: ING5 knockdown
enhances migration and invasion of lung cancer cells by inducing
EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways.
Oncotarget. 8:54265–54276. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Cai L, Li H, Chen C, Cheng X, Wang Y, Liu
J, Wang Y and Hao L: Role of inhibitor of growth 4 in the
suppression of human melanoma cells through the Fas/FasL-mediated
apoptosis pathway. Int J Mol Med. 41:1055–1061. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Suzuki S, Nozawa Y, Tsukamoto S, Kaneko T,
Imai H and Minami N: ING3 is essential for asymmetric cell division
during mouse oocyte maturation. PLoS One. 8(e74749)2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li X, Zhang Q, Zhang M, Luo Y and Fu Y:
Downregulation of nuclear ING3 expression and translocalization to
cytoplasm promotes tumorigenesis and progression in head and neck
squamous cell carcinoma (HNSCC). Histol Histopathol. 35:681–690.
2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lu M, Chen F, Wang Q, Wang K, Pan Q and
Zhang X: Downregulation of inhibitor of growth 3 is correlated with
tumorigenesis and progression of hepatocellular carcinoma. Oncol
Lett. 4:47–52. 2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
McClurg UL, Nabbi A, Ricordel C, Korolchuk
S, McCracken S, Heer R, Wilson L, Butler LM, Irving-Hooper BK,
Pedeux R, et al: Human ex vivo prostate tissue model system
identifies ING3 as an oncoprotein. Br J Cancer. 118:713–726.
2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Nabbi A, McClurg UL, Thalappilly S, Almami
A, Mobahat M, Bismar TA, Binda O and Riabowol KT: ING3 promotes
prostate cancer growth by activating the androgen receptor. BMC
Med. 15(103)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wang Y, Dai DL, Martinka M and Li G:
Prognostic significance of nuclear ING3 expression in human
cutaneous melanoma. Clin Cancer Res. 13:4111–4116. 2007.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhou R, Rotte A, Li G, Chen X, Chen G and
Bhandaru M: Nuclear localization of ING3 is required to suppress
melanoma cell migration, invasion and angiogenesis. Biochem Biophys
Res Commun. 527:418–424. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wu X, Chen C, Luo B, Yan D, Yan H, Chen F,
Guan F, Wu H and Yuan J: Nuclear ING3 expression is correlated with
a good prognosis of breast cancer. Front Oncol.
10(589009)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhao S, Wang L, Zhang C, Deng Y, Zhao B,
Ren Y, Fu Y and Meng X: Inhibitor of growth 3 induces cell death by
regulating cell proliferation, apoptosis and cell cycle arrest by
blocking the PI3K/AKT pathway. Cancer Gene Ther. 25:240–247.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Team C. Team RDC.R: A Language and
environment for statistical computing. R Foundation for Statistical
Computing, Vienna, Austria, 2012.
|
|
25
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474.
2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tang S, Pan H, Wei W, Yang H, Liu J and
Yang R: GOLPH3: A novel biomarker that correlates with poor
survival and resistance to chemotherapy in breast cancer.
Oncotarget. 8:105155–105169. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mayer IA and Arteaga CL: The PI3K/AKT
pathway as a target for cancer treatment. Annu Rev Med. 67:11–28.
2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Torres-Arzayus MI, Font de Mora J, Yuan J,
Vazquez F, Bronson R, Rue M, Sellers WR and Brown M: High tumor
incidence and activation of the PI3K/AKT pathway in transgenic mice
define AIB1 as an oncogene. Cancer Cell. 6:263–274. 2004.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Laurent C, Nicolae A, Laurent C, Le Bras
F, Haioun C, Fataccioli V, Amara N, Adélaïde J, Guille A, Schiano
JM, et al: Gene alterations in epigenetic modifiers and JAK-STAT
signaling are frequent in breast implant-associated ALCL. Blood.
135:360–370. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Jiang L, Zhao XH, Mao YL, Wang JF, Zheng
HJ and You QS: Long non-coding RNA RP11-468E2.5 curtails colorectal
cancer cell proliferation and stimulates apoptosis via the JAK/STAT
signaling pathway by targeting STAT5 and STAT6. J Exp Clin Cancer
Res. 38(465)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Davis RT, Blake K, Ma D, Gabra M,
Hernandez GA, Phung AT, Yang Y, Maurer D, Lefebvre A, Alshetaiwi H,
et al: Transcriptional diversity and bioenergetic shift in human
breast cancer metastasis revealed by single-cell RNA sequencing.
Nat Cell Biol. 22:310–320. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Matsumoto S, Yamamichi T, Shinzawa K,
Kasahara Y, Nojima S, Kodama T, Obika S, Takehara T, Morii E,
Okuyama H, et al: GREB1 induced by Wnt signaling promotes
development of hepatoblastoma by suppressing TGFβ signaling. Nat
Commun. 10(3882)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wellenstein MD, Coffelt SB, Duits D, van
Miltenburg MH, Slagter M, de Rink I, Henneman L, Kas SM, Prekovic
S, Hau CS, et al: Loss of p53 triggers WNT-dependent systemic
inflammation to drive breast cancer metastasis. Nature.
572:538–542. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Fink D, Yau T, Nabbi A, Wagner B, Wagner
C, Hu SM, Lang V, Handschuh S, Riabowol K and Rülicke T: Loss of
Ing3 expression results in growth retardation and embryonic death.
Cancers (Basel). 12(80)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yang C, Gao J, Yan N, Wu B, Ren Y, Li H
and Liang J: Propofol inhibits the growth and survival of gastric
cancer cells in vitro through the upregulation of ING3. Oncol Rep.
37:587–593. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Nabbi A, Almami A, Thakur S, Suzuki K,
Boland D, Bismar TA and Riabowol K: ING3 protein expression
profiling in normal human tissues suggest its role in cellular
growth and self-renewal. Eur J Cell Biol. 94:214–222.
2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Luo J, Shah S, Riabowol K and Mains PE:
The Caenorhabditis elegans ing-3 gene regulates ionizing
radiation-induced germ-cell apoptosis in a p53-associated pathway.
Genetics. 181:473–482. 2009.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Padmanaban V, Krol I, Suhail Y, Szczerba
BM, Aceto N, Bader JS and Ewald AJ: E-cadherin is required for
metastasis in multiple models of breast cancer. Nature.
573:439–444. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zeng Q, Michael IP, Zhang P, Saghafinia S,
Knott G, Jiao W, McCabe BD, Galván JA, Robinson H, Zlobec I, et al:
Synaptic proximity enables NMDAR signalling to promote brain
metastasis. Nature. 573:526–531. 2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Chen L, Yang S, Jakoncic J, Zhang JJ and
Huang XY: Migrastatin analogues target fascin to block tumour
metastasis. Nature. 464:1062–1066. 2010.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Goetz JG, Minguet S, Navarro-Lérida I,
Lazcano JJ, Samaniego R, Calvo E, Tello M, Osteso-Ibáñez T,
Pellinen T, Echarri A, et al: Biomechanical remodeling of the
microenvironment by stromal caveolin-1 favors tumor invasion and
metastasis. Cell. 146:148–163. 2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
de Sousa Abreu R, Penalva LO, Marcotte EM
and Vogel C: Global signatures of protein and mRNA expression
levels. Mol Biosyst. 5:1512–1526. 2009.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Maier T, Güell M and Serrano L:
Correlation of mRNA and protein in complex biological samples. FEBS
Lett. 583:3966–3973. 2009.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Chen G, Wang Y, Garate M, Zhou J and Li G:
The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated
ubiquitin-proteasome system. Oncogene. 29:1498–1508.
2010.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Tallen G and Riabowol K: Keep-ING balance:
Tumor suppression by epigenetic regulation. FEBS Lett.
588:2728–2742. 2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Roe JS, Hwang CI, Somerville TDD, Milazzo
JP, Lee EJ, Da Silva B, Maiorino L, Tiriac H, Young CM, Miyabayashi
K, et al: Enhancer reprogramming promotes pancreatic cancer
metastasis. Cell. 170:875–888.e20. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Weissmueller S, Manchado E, Saborowski M,
Morris JP VI, Wagenblast E, Davis CA, Moon SH, Pfister NT,
Tschaharganeh DF, Kitzing T, et al: Mutant p53 drives pancreatic
cancer metastasis through cell-autonomous PDGF receptor β
signaling. Cell. 157:382–394. 2014.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Santen RJ, Veldhuis J, Samojlik E, Lipton
A, Harvey H and Wells SA: Mechanism of action of aminoglutethimide
in breast cancer. Lancet. 1:44–45. 1979.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Li J, Cheng D, Zhu M, Yu H, Pan Z, Liu L,
Geng Q, Pan H, Yan M and Yao M: OTUB2 stabilizes U2AF2 to promote
the Warburg effect and tumorigenesis via the AKT/mTOR signaling
pathway in non-small cell lung cancer. Theranostics. 9:179–195.
2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Wu X, Zhou Z, Xu S, Liao C, Chen X, Li B,
Peng J, Li D and Yang L: Extracellular vesicle packaged
LMP1-activated fibroblasts promote tumor progression via autophagy
and stroma-tumor metabolism coupling. Cancer Lett. 478:93–106.
2020.PubMed/NCBI View Article : Google Scholar
|
